Magnetic resonance elastography

Canon Medical and Resoundant, Inc. Partnership to Provide Magnetic Resonance Elastography on Canon MRI Scanners

Retrieved on: 
Tuesday, November 30, 2021
Radiology, Health, Medical Devices, Patient, Mayo Clinic, American College of Radiology, Heart, Mayo Foundation for Medical Education & Research v. United States, CEO, Safety, Technology, Noise, AI, General manager, AICE, Health care, ReSound, Google Images, NAFLD, Fatty liver disease, MD, Diagnosis, Canon Medical Systems Corporation, Health, Radiology, Appropriate use criteria, Solution, MRE, Magnetic resonance elastography, Trust, Cirrhosis, Research, Non-alcoholic fatty liver disease, Medical education, Ministry of Education (Malaysia), MRI, American College, NASH, CT, Medical research, Nuclear medicine, Life, Blanche, Quality of life, Medical imaging, MRE, Resoundant, Canon Medical Systems, MRE, RESOUNDANT, CANON MEDICAL SYSTEMS

Canon Medical Systems Corporation and Resoundant, Inc. (Rochester, MN, USA) have signed a licensing agreement for the purpose of incorporating the advanced Magnetic Resonance Elastography (MRE), developed by Resoundant on the Canon MRI platforms.

Key Points: 
  • Canon Medical Systems Corporation and Resoundant, Inc. (Rochester, MN, USA) have signed a licensing agreement for the purpose of incorporating the advanced Magnetic Resonance Elastography (MRE), developed by Resoundant on the Canon MRI platforms.
  • Canon Medical and Resoundant have been working closely together to implement a seamless integration of the latest MRE technology on Canons newest line of MRI scanners.
  • MR Elastography was invented at Mayo Clinic and is the only MRI technology that has been validated for staging liver fibrosis.
  • Resoundant, Inc. is a medical technology company dedicated to improving patient care and diagnosis accuracy by making Magnetic Resonance Elastography (MRE) available around the world.

DURECT Corporation Presents Additional Clinical Data from DUR-928 Phase 1b Trial in NASH and Phase 1 Trial in Hepatic Impairment at the International Liver Conference 2021 (EASL)

Retrieved on: 
Wednesday, June 23, 2021
Medical specialties, Medical imaging, Health, Alcohol and health, Anatomy, Hepatitis, Liver, Liver disease, Cirrhosis, Non-alcoholic fatty liver disease, Elastography, Magnetic resonance elastography

CUPERTINO, Calif., June 23, 2021 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced the presentation of additional clinical data from a DUR-928 Phase 1b trial in non-alcoholic steatohepatitis (NASH) and a Phase 1 trial in subjects with hepatic impairment (HI) as part of two posters at the 2021 International Liver Conference (EASL) being held virtually June 23-26, 2021.

Key Points: 
  • CUPERTINO, Calif., June 23, 2021 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced the presentation of additional clinical data from a DUR-928 Phase 1b trial in non-alcoholic steatohepatitis (NASH) and a Phase 1 trial in subjects with hepatic impairment (HI) as part of two posters at the 2021 International Liver Conference (EASL) being held virtually June 23-26, 2021.
  • "We are pleased to report additional signals of potential efficacy from our Phase 1b NASH trial of DUR-928, our lead epigenetic regulator," saidJames E. Brown, D.V.M., President and CEO ofDURECT.
  • In addition, the Phase 1 trial in subjects with moderate and severe hepatic function impairment further demonstrates DUR-928's safety and potential efficacy profile in subjects with serious liver disease.
  • Improvement from baseline in liver stiffness, assessed by transient elastography (TE), magnetic resonance elastography (MRE) and the liver fibrosis marker pro-C3.

The elastography imaging market size is expected to grow from USD 2.5 billion in 2018 to USD 4.6 billion by 2024, at a compound annual growth rate (CAGR) of 11.0%

Retrieved on: 
Tuesday, April 16, 2019
RTT, Medical imaging, Elastography, Breast cancer, Cancer, Liver disease, Health, Medicine, Magnetic resonance elastography, Branches of biology

NEW YORK, April 16, 2019 /PRNewswire/ -- Growing incidence of breast cancer and chronic liver diseases is expected to drive the overall growth of the elastography imaging market.

Key Points: 
  • NEW YORK, April 16, 2019 /PRNewswire/ -- Growing incidence of breast cancer and chronic liver diseases is expected to drive the overall growth of the elastography imaging market.
  • The elastography imaging market size is expected to grow from USD 2.5 billion in 2018 to USD 4.6 billion by 2024, at a compound annual growth rate (CAGR) of 11.0% during the forecast period.
  • The elastography imaging market is growing incidence of breast cancer and chronic liver diseases, and a rising preference for minimally invasive procedures across the globe are the key factors driving the market.
  • Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

MRI "Glove" Provides New Look at Hand Anatomy

Retrieved on: 
Wednesday, May 9, 2018
Magnetic resonance imaging, Medicine, Cryogenics, Medical physics, Radiofrequency coil, Magnetic resonance, Medical imaging, Health, Osteochondritis dissecans, Magnetic resonance elastography

Since its emergence in the 1970s, magnetic resonance imaging (MRI) has given physicians a better look inside tissues, helping to diagnose millions of maladies per year, from brain tumors to internal bleeding to torn ligaments.

Key Points: 
  • Since its emergence in the 1970s, magnetic resonance imaging (MRI) has given physicians a better look inside tissues, helping to diagnose millions of maladies per year, from brain tumors to internal bleeding to torn ligaments.
  • Also fundamental to MRI is the ability of radiofrequency coils to convert radio waves into a detectable electric current.
  • Once the best arrangement is set, coils can no longer move relative to one another, constraining the ability of MRI to image complex, moving joints.
  • For this reason, MRI is great at imaging muscles, nerves, and even cartilage, which are difficult to study using other non-invasive methods.